LifeSignals Showcases the UbiqVue™ 2A Multiparameter System for Active Patient Monitoring

Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings
• Replaces time-consuming manual spot checking with continuous, near real-time* active patient monitoring
• Web-based system displays multiple patient physiological data continuously, with visual alarms and alert notifications for streamlined patient care
• Developed to support scalable population health management
• EU MDR and FDA 510(k) Cleared

LifeSignals will be showcasing the UbiqVue 2A Multiparameter System, a continuous wireless patient monitoring system for in-hospital and at-home settings.
Central to the system is the UbiqVue 2A wearable Biosensor, a single-use, all-in-one wearable device that enables SpO2** to be continuously collected from the chest, alongside other biodata, for generating a total of twelve monitored parameters, including 2-channel ECG, pulse rate, PPG, respiration rate, body temperature, and motion. The encrypted data is securely transmitted, in near real-time, from the Biosensor via a relay device to a secure cloud-based system, where it is further signal-processed. Healthcare professionals and care providers can access continuous vital signs, via the UbiqVue web portal, and receive alert notifications.

LifeSignals will also present the UbiqVue™ Holter System incorporating the UbiqVue 2AYe wearable Biosensor that continuously collects 2-channel ECG and event data for up to 8 days***. Encrypted data is securely transmitted directly from the Biosensor, via the patient-facing app to a secure cloud-based system throughout the monitoring period. Within minutes of Holter test completion, the patient’s data is automatically processed by cloud-based ECG analytics—significantly reducing certified cardiac technician over-read time and enabling report delivery within hours for physician review and sign-off.

The UbiqVue Systems are expected to play a vital role in advancing both individual patient care and broader population health strategies, reinforcing LifeSignals’ mission to deliver innovative, wireless solutions for healthcare systems worldwide.

Learn more by visiting: https://www.lifesignals.com  or visit us in the Wearable Technology Pavilion Hall 12, C31.
‍

* Latency of less than 10 seconds with internet connectivity.

** White light spectral SpO2 patented technology licensed from BioIntelliSense, Inc. LifeSignals, Inc. in partnership with BioIntelliSense, carried out the product-level design and processing technology enhancements enabling reliable, continuous SpO2 monitoring and accurate performance across all skin tones in a chest-worn Biosensor.

*** US 5-day wear.